1 Global BioPharmaceutical Tubing Market Insight Analysis
The global biopharmaceutical tubing market is valued at USD 3728.79 million in 2024, with a CAGR of approximately 7.27% from 2024 to 2033.
Biopharmaceutical tubing are specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment. They confer exceptional thermal, mechanical, and chemical properties.
Figure Global BioPharmaceutical Tubing Market Size (M USD) and CAGR (2024-2033)
2 BioPharmaceutical Tubing Market Growth Drivers and Restraints
In terms of driving factors: First, the growth in demand for minimally invasive medical surgeries has significantly driven market development. Minimally invasive medical treatments have become increasingly popular in recent years due to their advantages such as small incisions, fast patient recovery and less discomfort. For example, the treatment of arthritis, cancer and cardiovascular diseases has greatly increased the demand for minimally invasive surgeries, and as key components, the demand for catheters and biopharmaceutical tubing has also increased dramatically. Taking cardiac and urinary catheterization as an example, the use of catheter tubing can greatly shorten medical or surgical time and improve efficiency, which has led to a continuous increase in the demand for biopharmaceutical tubing market.
Second, the increase in the elderly population has also greatly promoted market growth. The proportion of the elderly population in the world continues to rise. According to data from the World Health Organization (WHO), by 2050, the proportion of the global population over 60 years old will nearly double. The increase in the elderly population has led to an increase in the prevalence of elderly diseases, and a significant increase in demand for diagnostic equipment, drug delivery systems, and urology catheters, which in turn has driven the demand for the application of biopharmaceutical tubing in related medical equipment.
Third, the increasing investment of emerging economies in the healthcare industry has created broad opportunities for the biopharmaceutical tubing market. Countries like Brazil, Russia, India, China and South Africa (BRICS) have experienced rapid economic development, increased government investment in medical facilities, and increased consumer purchasing power, which has led to the rapid development of the healthcare industry, thereby driving the growth of the biopharmaceutical tubing market.
Restrictive factors: First, the market competition is fierce. There are many biopharmaceutical tubing manufacturers around the world, and the competition is fierce. In order to gain a foothold in the market, major companies have provided high-quality products at low prices, which has led to lower industry profits and limited the market’s revenue growth. Many small companies or retailers have also continued to enter the market, and some of them also provide low-quality counterfeit products, making market competition more chaotic, disrupting the market order, and not conducive to the sustainable development of the industry.
Second, product research and development requires a lot of investment and time. The manufacturing process of biopharmaceutical tubing is complex, which not only requires high capital investment, but also a long research and development cycle. Moreover, delays in regulatory approval will further prolong the overall development process, increase corporate costs, and reduce corporate investment enthusiasm in medical product development technology. In addition, in order to ensure the safety and biocompatibility of products, companies need to invest a lot of time and energy in research and testing, which also hinders the development of the market to a certain extent.
3 Technological Innovations in the BioPharmaceutical Tubing Market
In terms of technological innovation, material innovation is a key area. Silicone tubing has occupied an important market share in 2021 due to its non-toxic, clean, and high temperature resistant properties. Many companies continue to invest in research and development to continuously optimize the performance of silicone tubing. For example, in September 2021, DuPont launched the DuPont Liveo series of silicone medical solutions, including pharmaceutical tubing and molded components for biopharmaceutical processing, transdermal and topical drug delivery systems, etc., meeting the market demand for high-quality, multifunctional tubing.
Companies also spare no effort in product innovation and continue to launch new products to adapt to market changes. In order to meet consumers’ pursuit of product convenience and functionality, companies are committed to developing easier-to-use and better-performing biopharmaceutical tubing. For example, some companies have developed tubing with special functions, such as better fluid transmission performance, higher chemical resistance, or more convenient connection methods. These innovative products help companies stand out in market competition.
4 Global BioPharmaceutical Tubing Market Size by Type
Plastics are one of the most widely used materials in BioPharmaceutical Tubing due to their versatility, cost-effectiveness, and ability to be tailored for various applications. In 2024, the market value for plastic tubing is expected to reach $1,231.13 million, accounting for approximately 33.02% of the total market share. This segment is driven by the growing demand for disposable medical devices and tubing used in drug delivery systems, peristaltic pumps, and other minimally invasive procedures. The use of plastics in BioPharmaceutical Tubing is particularly advantageous due to their flexibility, chemical resistance, and ease of sterilization.
Silicone tubing is highly valued in the medical and biopharmaceutical industries for its biocompatibility, thermal stability, and resistance to extreme temperatures. In 2024, the market value for silicone tubing is projected to be $1,576.15 million, representing 42.27% of the total market share. This segment is expected to continue growing due to its widespread use in applications such as catheters, cardiovascular devices, and other critical medical equipment. Silicone’s ability to maintain its properties under harsh conditions and its non-toxic nature make it an ideal material for medical tubing.
Glass tubing is known for its excellent chemical resistance, clarity, and precision, making it suitable for applications where purity and accuracy are paramount. In 2024, the market value for glass tubing is expected to reach $477.40 million, holding a market share of 12.80%. Glass tubing is commonly used in laboratory equipment, pharmaceutical packaging, and other applications requiring high-purity fluid handling. The segment’s growth is driven by the increasing demand for high-precision medical devices and the need for reliable, non-reactive materials in biopharmaceutical processes.
Metal tubing, although a smaller segment, plays a crucial role in specific applications requiring high strength and durability. In 2024, the market value for metal tubing is projected to be $444.10 million, accounting for 11.91% of the total market share. Metals such as stainless steel and titanium are used in applications such as stents, guidewires, and other invasive devices. The growth of this segment is driven by the increasing demand for durable and reliable tubing solutions in cardiovascular and orthopedic applications.
Table Global BioPharmaceutical Tubing Market Size and Share by Type in 2024
Type | Market Size (M USD) 2024 | Market Share 2024 |
|---|---|---|
Plastics | 1231.13 | 33.02% |
Silicone | 1576.15 | 42.27% |
Glass | 477.40 | 12.80% |
Metals | 444.10 | 11.91% |
5 Global BioPharmaceutical Tubing Market Size by Application
Hospitals & clinics held the largest market share in 2024, with a market value of approximately $1,685.50 million, accounting for 45.20% of the total market value. This significant share is due to the extensive use of biopharmaceutical tubing in a wide range of medical procedures and patient care activities. For example, in drug delivery systems, tubing is crucial for the safe and efficient transfer of medications to patients. In addition, in dialysis and cardiac bypass procedures, the high – quality tubing ensures the proper flow of fluids, which is essential for patient treatment.
Ambulatory surgical centers ranked second, with a market value of around $1,221.93 million and a market share of 32.77%. These centers are increasingly performing a variety of surgical procedures, which drives the demand for biopharmaceutical tubing. The tubing is used in minimally invasive surgeries, where it helps in the delivery of surgical tools and the transfer of fluids during the procedures.
Medical labs had a market value of about $640.61 million in 2024, representing a market share of 17.18%. In medical labs, biopharmaceutical tubing is used for tasks such as reagent dispensing, cell culture media transfer, and diagnostic equipment operation. The accurate and sterile transfer of substances is vital for the reliability of laboratory tests, making high – quality tubing indispensable.
Table Global BioPharmaceutical Tubing Market Size and Share by Application in 2024
Application | Market Size (M USD) 2024 | Market Share 2024 |
|---|---|---|
Hospitals & Clinics | 1685.50 | 45.20% |
Ambulatory Surgical Centers | 1221.93 | 32.77% |
Medical Labs | 640.61 | 17.18% |
Others | 180.75 | 4.85% |
6 Global BioPharmaceutical Tubing Market Size by Region
North America was a major market in 2024, with a market value of approximately $1,445.32 million, accounting for 38.76% of the total market value. The region has a highly developed healthcare system, with advanced medical research and a large patient population. The presence of numerous pharmaceutical and medical device companies in North America drives the demand for biopharmaceutical tubing. For example, in the United States, the large – scale investment in healthcare and the high – tech medical industry contribute to the high consumption of tubing. The well – established regulatory environment also ensures the quality and safety of products, which is conducive to the market’s growth.
Europe followed closely, with a market value of around $1,239.89 million and a market share of 33.25%. Europe has a long – standing reputation for its advanced medical technology and high – quality healthcare services. Countries like Germany, the UK, and France have a strong presence in the biopharmaceutical industry. The region’s focus on innovation in medical devices and the aging population’s increasing demand for healthcare services are the main factors promoting the growth of the biopharmaceutical tubing market. For instance, Germany’s advanced manufacturing capabilities and research – driven approach in the medical field support the demand for high – end tubing products.
The Asia Pacific region was a rapidly growing market in 2024, with a market value of about $842.48 million and a market share of 22.59%. The region’s growth is mainly attributed to the increasing investment in healthcare infrastructure, a large and growing population, and the rising awareness of healthcare. China, in particular, has seen significant growth in its biopharmaceutical and medical device industries in recent years. The government’s support for the healthcare sector, along with the growing middle – class population’s increasing purchasing power, has led to a surge in demand for biopharmaceutical tubing. Additionally, countries like Japan and South Korea also contribute to the market growth with their advanced medical research and manufacturing capabilities.
South America had a market value of around $109.28 million in 2024, accounting for 2.93% of the total market. Although its market share is relatively small compared to other regions, countries like Brazil are showing potential for growth. Brazil has a large population and is gradually increasing its investment in the healthcare industry. However, the region also faces challenges such as economic instability in some countries, which may affect the growth rate of the biopharmaceutical tubing market.
The Middle East & Africa had a market value of approximately $91.81 million and a market share of 2.46% in 2024. The region’s market growth is driven by factors such as the increasing government spending on healthcare in some countries, especially in the Gulf Cooperation Council (GCC) states. However, challenges like the uneven development of healthcare systems in different countries and the impact of economic fluctuations on healthcare investment still exist. For example, countries in the Middle East are investing in building advanced healthcare facilities, which creates opportunities for the biopharmaceutical tubing market, but the overall economic situation in some African countries may limit the market’s expansion.
Figure Global BioPharmaceutical Tubing Market Size (M USD) by Region in 2024
7 Global BioPharmaceutical Tubing Market Analysis by Major Players
Saint-Gobain
Company Introduction and Business Overview:
Saint-Gobain is a global leader in the design, manufacture, and distribution of materials and solutions that enhance the well-being of individuals and the future of all. Established in 1665, the company is headquartered in France and operates worldwide. Saint-Gobain’s extensive product portfolio includes high-performance materials used in various industries, including biopharmaceutical tubing.
Saint-Gobain’s business is characterized by a strong commitment to innovation and sustainability. The company’s strategy focuses on providing cutting-edge solutions that meet the evolving needs of the biopharmaceutical industry. During the COVID-19 pandemic, Saint-Gobain implemented robust business continuity plans to ensure the uninterrupted supply of critical materials, prioritizing employee safety and customer satisfaction. The company’s ability to adapt and innovate has solidified its position as a reliable partner in the healthcare and medical device sectors.
Products:
Saint-Gobain offers a range of biopharmaceutical tubing products, including C-Flex® thermoplastic elastomer tubing. C-Flex® is specifically designed for aseptic welding connections and sealing disconnections, making it ideal for single-use assemblies and overmolds. The tubing is manufactured from pharmaceutical-grade thermoplastic elastomer, ensuring compliance with USP Class VI and ISO standards. Its features include non-pyrogenicity, non-cytotoxicity, non-hemolytic properties, and a smooth inner bore for superior fluid flow. These attributes make C-Flex® tubing a preferred choice for applications such as drug delivery systems, peristaltic pumps, and biopharmaceutical laboratory equipment.
Corning
Company Introduction and Business Overview:
Corning is a leading innovator in materials science, with a history spanning over 169 years. Headquartered in the United States, Corning specializes in the development and production of high-quality glass and ceramic materials. The company’s products are widely used in various industries, including telecommunications, automotive, and healthcare. Corning’s commitment to research and development has resulted in groundbreaking innovations that have transformed multiple sectors.
Corning’s business strategy is centered around leveraging its expertise in glass science, ceramics science, and optical physics to develop category-defining products. The company’s operations are guided by a strong focus on sustainability and environmental responsibility. During the COVID-19 pandemic, Corning played a crucial role in the production of glass vials for vaccine delivery, showcasing its ability to contribute to global health initiatives. Corning’s dedication to innovation and quality has positioned it as a trusted supplier to the biopharmaceutical industry.
Products:
Corning offers a variety of biopharmaceutical tubing products, including high-quality borosilicate glass tubing. This tubing is ideal for pharmaceutical applications due to its exceptional chemical resistance, thermal stability, and clarity. Corning’s glass tubing is used to manufacture vials, cartridges, ampules, and syringes, ensuring the safe and effective storage and delivery of pharmaceuticals. The company’s FIOLAX® and BORO-8330™ brands are renowned for their reliability and compliance with stringent industry standards, making them preferred choices for primary packaging solutions in the biopharmaceutical sector.
Teleflex
Company Introduction and Business Overview:
Teleflex is a global provider of medical technologies designed to improve the health and quality of life for patients. Established in 1943, the company is headquartered in the United States and operates worldwide. Teleflex’s portfolio includes a wide range of medical devices and solutions, with a strong focus on vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine, and respiratory care.
Teleflex’s business strategy is driven by a relentless pursuit of innovation and a commitment to addressing unmet clinical needs. The company’s operations are guided by stringent quality standards and a dedication to patient safety. During the COVID-19 pandemic, Teleflex implemented comprehensive health and safety guidelines to ensure the continued supply of critical medical devices. The company’s robust business continuity plans allowed it to maintain operations and support healthcare providers on the front lines of the pandemic.
Products:
Teleflex offers a range of biopharmaceutical tubing products, including ultra-small polyimide tubing used in peripheral vascular, cardiology, and neurology applications. The company’s capabilities include reinforced and conductor-embedded tubing designs, constructed from materials such as polyimide, PTFE, thermoplastics, and hybrid blends. Teleflex’s polyimide tubing is known for its durability, flexibility, and resistance to repeated changes in bending, pressure, and tension. These attributes make it ideal for applications such as catheters, guidewires, and other minimally invasive devices. Teleflex’s commitment to quality and innovation ensures that its tubing products meet the highest standards of performance and reliability in the biopharmaceutical industry.